Enterprise Value
154.8M
Cash
17.31M
Avg Qtr Burn
-4.952M
Short % of Float
0.21%
Insider Ownership
0.20%
Institutional Own.
18.19%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LTI-01 Details Loculated pleural effusions | Phase 2b Initiation | |
LTI-03 Details Idiopathic pulmonary fibrosis | Phase 1b Data readout | |
ALRN-6924 Details Cancer, Breast cancer | Failed Discontinued | |
ALRN-6924 Details Cancer, Non-small cell lung carcinoma | Failed Discontinued | |
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s | Failed Discontinued |